Anti-CEA CAR T cell therapy (Roger Williams Medical Center)

N/A

Report date: 2022/05/20 16:06:12

Base Information

Drug NameAnti-CEA CAR T cell therapy (Roger Williams Medical Center)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapyCell and gene therapy > Gene therapy

Mechanisms of ActionCarcinoembryonic antigen related cell adhesion molecule 5 antagonists

TargetsCarcinoembryonic antigen related cell adhesion molecule 5

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesRoger Williams Medical Center

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesRoger Williams Medical Center

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A